This narrative review examines whether the endocannabinoid system may play a biochemical role in ADHD pathophysiology. It gathers 11 preclinical and 2 clinical studies and argues that ECS signaling may intersect with attention, impulsivity, and hyperactivity pathways. The core limitation is that the evidence remains thin, heavily preclinical, and far from proving that cannabinoid-based treatments are ready for clinical use in ADHD.

Read More

Tylenol and Autism: 7 Insights You Need Now

Tylenol has long been the go-to pain reliever during pregnancy, but a new wave of research questions its safety.

This post unpacks the science, the panic, and the human stories behind the headlines on Tylenol and autism.

The truth? Itโ€™s complicated, but clarityโ€”and compassionโ€”are possible.

Read More